LGALS3 and prostate carcinoma: Geisler et al. determined the amount of prostatic acid phosphatase (PAP), vinculin, and galectin-3 by SRM specific to the urine of control patients, non-relapsing prostate cancer patients, and relapsing prostate cancer patients.